Literature DB >> 12872226

Profiling the progression of cancer: separation of microsomal proteins in MCF10 breast epithelial cell lines using nonporous chromatophoresis.

Kimberly A O'Neil1, Fred R Miller, Timothy J Barder, David M Lubman.   

Abstract

The heterogeneity of cellular protein expression has stimulated development of separations targeting smaller groups of related proteins rather than entire proteomes. The following work describes the development of a technique for the characterization of membrane subproteomes from five different breast epithelial cell lines. Intact membrane proteins are separated by hydrophobicity in the first dimension using nonporous reversed-phase high-performance liquid chromatography (RP-HPLC) to generate unique chromatographic profiles. Fractions of eluent are further separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to create distinct banding patterns. This hybrid liquid phase/gel phase method circumvents issues of membrane protein precipitation and provides a simple strategy aimed at isolating and characterizing a traditionally underrepresented protein class. Membrane protein profiles are created that discriminate between microsomal fractions of breast epithelial cells in different stages of neoplastic progression. Proteins are subsequently identified using matrix-assisted laser desorption/ionization - mass spectrometry (MALDI-MS) mass fingerprinting and MALDI-quadrupole time of flight - tandem mass spectrometry (QTOF-MS/MS) peptide sequencing. Furthermore, as this strategy preserves intact protein structure, further characterization can be performed on proteins producing mass fingerprint spectra and fragmentation spectra that did not result in database protein identifications. The coupling of nonporous RP-HPLC with SDS-PAGE provides a useful alternative to two-dimensional PAGE (2-D-PAGE) for membrane protein analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872226     DOI: 10.1002/pmic.200300446

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  7 in total

1.  Protein separation and characterization by np-RP-HPLC followed by intact MALDI-TOF mass spectrometry and peptide mass mapping analyses.

Authors:  Claire Dauly; David H Perlman; Catherine E Costello; Mark E McComb
Journal:  J Proteome Res       Date:  2006-07       Impact factor: 4.466

2.  Formaldehyde up-regulates TRPV1 through MAPK and PI3K signaling pathways in a rat model of bone cancer pain.

Authors:  Ying Han; Yan Li; Xing Xiao; Jia Liu; Xiang-Ling Meng; Feng-Yu Liu; Guo-Gang Xing; You Wan
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

3.  Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.

Authors:  Ziad J Sahab; Yan-Gao Man; Suzan M Semaan; Robert G Newcomer; Stephen W Byers; Qing-Xiang Amy Sang
Journal:  Clin Exp Metastasis       Date:  2010-07-03       Impact factor: 5.150

4.  Methodology and applications of disease biomarker identification in human serum.

Authors:  Ziad J Sahab; Suzan M Semaan; Qing-Xiang Amy Sang
Journal:  Biomark Insights       Date:  2007-02-14

Review 5.  Breast tumor metastasis: analysis via proteomic profiling.

Authors:  Steve Goodison; Virginia Urquidi
Journal:  Expert Rev Proteomics       Date:  2008-06       Impact factor: 3.940

6.  Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach.

Authors:  Yanfei Wang; Xiaoping Ao; Huy Vuong; Meghana Konanur; Fred R Miller; Steve Goodison; David M Lubman
Journal:  J Proteome Res       Date:  2008-08-27       Impact factor: 4.466

7.  Central carbon metabolism in the progression of mammary carcinoma.

Authors:  Adam D Richardson; Chen Yang; Andrei Osterman; Jeffrey W Smith
Journal:  Breast Cancer Res Treat       Date:  2007-09-19       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.